Utah Medical Products, Inc. UTM.F Stock
Utah Medical Products, Inc. Price Chart
Utah Medical Products, Inc. UTM.F Financial and Trading Overview
Utah Medical Products, Inc. stock price | 65.5 EUR |
Previous Close | 88.5 EUR |
Open | 86.5 EUR |
Bid | 86.5 EUR x N/A |
Ask | 87.5 EUR x N/A |
Day's Range | 86.5 - 86.5 EUR |
52 Week Range | 79 - 97.5 EUR |
Volume | 200 EUR |
Avg. Volume | 7 EUR |
Market Cap | 313.83M EUR |
Beta (5Y Monthly) | 0.194366 |
PE Ratio (TTM) | 19.52596 |
EPS (TTM) | 4.26 EUR |
Forward Dividend & Yield | 1.07 (1.16%) |
Ex-Dividend Date | June 15, 2023 |
1y Target Est | N/A |
UTM.F Valuation Measures
Enterprise Value | 255.01M EUR |
Trailing P/E | 19.52596 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 5.9801836 |
Price/Book (mrq) | 2.6591656 |
Enterprise Value/Revenue | 4.859 |
Enterprise Value/EBITDA | 9.203 |
Trading Information
Utah Medical Products, Inc. Stock Price History
Beta (5Y Monthly) | 0.194366 |
52-Week Change | 14.90% |
S&P500 52-Week Change | 20.43% |
52 Week High | 97.5 EUR |
52 Week Low | 79 EUR |
50-Day Moving Average | 86.62 EUR |
200-Day Moving Average | 87.46 EUR |
UTM.F Share Statistics
Avg. Volume (3 month) | 7 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 3.63M |
Float | 3.19M |
Short Ratio | N/A |
% Held by Insiders | 6.46% |
% Held by Institutions | 72.53% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.17 |
Trailing Annual Dividend Yield | 1.32% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.24790001 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 32.68% |
Operating Margin (ttm) | 39.49% |
Gross Margin | 61.94% |
EBITDA Margin | 52.80% |
Management Effectiveness
Return on Assets (ttm) | 10.46% |
Return on Equity (ttm) | 15.10% |
Income Statement
Revenue (ttm) | 52.48M EUR |
Revenue Per Share (ttm) | 14.46 EUR |
Quarterly Revenue Growth (yoy) | 1.60% |
Gross Profit (ttm) | 32.2M EUR |
EBITDA | 27.71M EUR |
Net Income Avi to Common (ttm) | 17.15M EUR |
Diluted EPS (ttm) | 4.43 |
Quarterly Earnings Growth (yoy) | 19.19% |
Balance Sheet
Total Cash (mrq) | 80.91M EUR |
Total Cash Per Share (mrq) | 22.3 EUR |
Total Debt (mrq) | 328K EUR |
Total Debt/Equity (mrq) | 0.28 EUR |
Current Ratio (mrq) | 15.659 |
Book Value Per Share (mrq) | 32.529 |
Cash Flow Statement
Operating Cash Flow (ttm) | 23.02M EUR |
Levered Free Cash Flow (ttm) | 18.94M EUR |
Profile of Utah Medical Products, Inc.
Country | Germany |
State | UT |
City | Midvale |
Address | 7043 South 300 West |
ZIP | 84047-1048 |
Phone | 801 566 1200 |
Website | https://www.utahmed.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 186 |
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Q&A For Utah Medical Products, Inc. Stock
What is a current UTM.F stock price?
Utah Medical Products, Inc. UTM.F stock price today per share is 65.5 EUR.
How to purchase Utah Medical Products, Inc. stock?
You can buy UTM.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Utah Medical Products, Inc.?
The stock symbol or ticker of Utah Medical Products, Inc. is UTM.F.
Which industry does the Utah Medical Products, Inc. company belong to?
The Utah Medical Products, Inc. industry is Medical Instruments & Supplies.
How many shares does Utah Medical Products, Inc. have in circulation?
The max supply of Utah Medical Products, Inc. shares is 3.59M.
What is Utah Medical Products, Inc. Price to Earnings Ratio (PE Ratio)?
Utah Medical Products, Inc. PE Ratio is 15.37558600 now.
What was Utah Medical Products, Inc. earnings per share over the trailing 12 months (TTM)?
Utah Medical Products, Inc. EPS is 4.26 EUR over the trailing 12 months.
Which sector does the Utah Medical Products, Inc. company belong to?
The Utah Medical Products, Inc. sector is Healthcare.